Affect of conviction on life span in lung cancer
PDF
Cite
Share
Request
Clinical Research
VOLUME: 28 ISSUE: 2
P: 116 - 120
2018

Affect of conviction on life span in lung cancer

Anatol J Gen Med Res 2018;28(2):116-120
1. Sağlık Bilimleri University, İzmir Dr Suat Seren Chest Diseases And Thoracic Surgery, Chest Diseases, İzmir
2. Turgutlu State Hospital, Chest Diseases, Manisa
No information available.
No information available
Received Date: 2018-02-15T14:46:10
Accepted Date: 2018-07-31T15:33:16
PDF
Cite
Share
Request

Abstract

INTRODUCTION

The mortality and the characteristics of the patients who have been convicted and diagnosed as lung cancer were not clear. It is aimed to compare survival of patients with prisoner lung cancer and the general population.

METHODS

57 patients with 27 from prisoner and 30 of general populations with lung cancer who followed up between 2010 and 2014 included in this study. The study was designed as retrospective case series. The patients' age, life span, duration of symptoms, largest tumor diameter in thorax CT, routine biochemical and hemogram values were recorded.

RESULTS

Fifty-seven patients who were male were included in the study. The mean age was 60.46 years. The most common stage was stage 4 disease in both groups. The most frequent site of metastases was the lung, and the most common location was the location of the upper lobe. Symptom duration, calcium, C-reactive protein and sedimentation values were significantly higher in the prisoner groups (p <0.01). When compared with respect to survival; shorter life spans were found in prisoner lung cancer patients than in the general population.

DISCUSSION AND CONCLUSION

Lung cancer in convicted population has a shorter life span compared to lung cancer diagnosed in the general population.

Keywords:
Lung cancer, prisoner, survival.